Naproxen
Pelvic Pain
Endeavor HealthSmall moleculePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 50/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Pelvic Pain cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
LIDOCAINE Queen's University | Phase 4 | BB |
Continuous Microgestin 1/20 Endeavor Health | Phase 4 | BB |
Cyclic Microgestin 1/20 Endeavor Health | Phase 4 | BB |
Nicotine Columbia University | Phase 4 | BB |
Oxytocin University of Calgary | Phase 2/3 | B |
View all 25 →
Same molecule, other indications
Naproxen is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →